• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEUROMD MEDICAL TECHNOLOGIES NEUROMD CORRECTIVE THERAPY DEVICE® FOR BACK PAIN; STIMULATOR, NERVE, TRANSCUTANEOUS, FOR PAIN RELIEF

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEUROMD MEDICAL TECHNOLOGIES NEUROMD CORRECTIVE THERAPY DEVICE® FOR BACK PAIN; STIMULATOR, NERVE, TRANSCUTANEOUS, FOR PAIN RELIEF Back to Search Results
Health Effect - Clinical Codes Erythema (1840); Hypersensitivity/Allergic reaction (1907); Itching Sensation (1943); Pain (1994); Scar Tissue (2060); Blister (4537)
Date of Event 12/20/2024
Type of Reportable Event Serious Injury
Event or Problem Description
One day, when i used the neuromd pad (https://getneuromd.Com/), i experienced immediate and severe skin redness.Within a few hours, i developed skin blistering, itching, and pain around my lower back area where the pad was applied.The healing process took two months, and i still have dry patches of skin and some scarring.I used the neuromd pads almost every day from (b)(6) 2023 until (b)(6) 2024, when the allergic reaction occurred quite suddenly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROMD CORRECTIVE THERAPY DEVICE® FOR BACK PAIN
Common Device Name
STIMULATOR, NERVE, TRANSCUTANEOUS, FOR PAIN RELIEF
Manufacturer (Section D)
NEUROMD MEDICAL TECHNOLOGIES
18201 collins ave 4309a
sunny isles beach FL 33160
MDR Report Key21333931
Report NumberMW5165765
Device Sequence Number8034774
Product Code GZJ
Combination Product (Y/N)N
Initial Reporter StateNH
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Voluntary
Initial Reporter Occupation Patient
Type of Report Initial
Report Date (Section B) 02/02/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Was Device Available for Evaluation? Yes
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date02/06/2025
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
COSAMIN DS JOINT HEALTH (1500 MG GLUCOSAMINE HCL+1200 MG CHONDROITIN SULFATE).; INTERMITTENT USE OF MELOXICAM 7.5 MG/ONCE A DAY.; TURMERIC 1000 MG WITH BLACK PEPPER (KIRKLAND).
Outcome Attributed to Adverse Event Other;
Patient Age64 YR
Patient SexFemale
Patient Weight61 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-